- Home
- LGND vs IDYA Comparison
LGND vs IDYA Comparison
Compare LGND & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- IDYA
- Stock Information
- Founded
- LGND 1987
- IDYA 2015
- Country
- LGND United States
- IDYA United States
- Employees
- LGND N/A
- IDYA N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- LGND Health Care
- IDYA Health Care
- Exchange
- LGND Nasdaq
- IDYA Nasdaq
- Market Cap
- LGND N/A
- IDYA 2.0B
- IPO Year
- LGND 1992
- IDYA 2019
- Fundamental
- Price
- LGND $107.62
- IDYA $17.05
- Analyst Decision
- LGND Strong Buy
- IDYA Strong Buy
- Analyst Count
- LGND 6
- IDYA 13
- Target Price
- LGND $145.00
- IDYA $53.58
- AVG Volume (30 Days)
- LGND 135.2K
- IDYA 901.3K
- Earning Date
- LGND 05-06-2025
- IDYA 05-06-2025
- Dividend Yield
- LGND N/A
- IDYA N/A
- EPS Growth
- LGND N/A
- IDYA N/A
- EPS
- LGND N/A
- IDYA N/A
- Revenue
- LGND $167,133,000.00
- IDYA $7,000,000.00
- Revenue This Year
- LGND $16.90
- IDYA $89.14
- Revenue Next Year
- LGND $18.27
- IDYA $291.34
- P/E Ratio
- LGND N/A
- IDYA N/A
- Revenue Growth
- LGND 27.28
- IDYA N/A
- 52 Week Low
- LGND $67.72
- IDYA $16.88
- 52 Week High
- LGND $129.90
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- LGND 44.36
- IDYA 31.80
- Support Level
- LGND $106.79
- IDYA $17.05
- Resistance Level
- LGND $112.49
- IDYA $18.90
- Average True Range (ATR)
- LGND 4.58
- IDYA 0.91
- MACD
- LGND 0.12
- IDYA 0.01
- Stochastic Oscillator
- LGND 43.87
- IDYA 6.27
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.